Dyadic®

Reinventing Biologic Vaccine and Drug Development & Production
Biopharmaceuticals As the aging population grows there is a critical need to bring biologic vaccines and drugs to market faster, with improved performance, in greater volumes to improve access and reduce costs to patients and the healthcare system. Find out more > C1 Technology Platform The industrially proven C1 Expression System has the potential to bring novel biologic drugs such as vaccines and antibodies to market faster, in greater volumes and at lower cost to patients and the healthcare system. Find out more > Research & Development The C1 technology platform is being used by leading global companies which includes BASF, DuPont and others. Find out more > Partnering & Licensing Dyadic is seeking partnerships to sub-license, or partner its C1 platform technology in the vaccine, antibody and biosimilar industries. Find out more >
Manufacturing We have industrial scale manufacturing expertise at up to 500,000 liter scale. Commercial products have been produced utilizing the C1 platform technology at industrial scale in 5 countries over 17 years. Find out more >
Biopharmaceuticals As the aging population grows there is a critical need to bring biologic vaccines and drugs to market faster, with improved performance, in greater volumes to improve access and reduce costs to patients and the healthcare system. Find out more > C1 Technology Platform The industrially proven C1 Expression System has the potential to bring novel biologic drugs such as vaccines and antibodies to market faster, in greater volumes and at lower cost to patients and the healthcare system. Find out more >
Research & Development The C1 technology platform is being used by leading global companies which includes BASF, DuPont and others. Find out more > Partnering & Licensing Dyadic is seeking partnerships to sub-license, or partner its C1 platform technology in the vaccine, antibody and biosimilar industries. Find out more >
Manufacturing We have industrial scale manufacturing expertise at up to 500,000 liter scale. Commercial products have been produced utilizing the C1 platform technology at industrial scale in 5 countries over 17 years. Find out more >

UPCOMING EVENTS

Diamond Equity Research Emerging Growth Invitational

September 25, 2019 - New York
Read More
VIEW ALL

Dyadic
Investor Center

LEARN MORE